Business Today
Subscribe
PMS TodayUS NewsIndiaUPSTARTWeatherBT ShortsNRIEducationElection
BT GolfBT MindrushBT Best Banks
Search

COMPANIES

No Data Found

NEWS

No Data Found
Advertisement
News
markets
stocks
Concord Drugs Ltd
Concord Drugs Ltd

Concord Drugs Ltd Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 6,341
Apr 25, 2025
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹30.39
₹-1.05 (-3.34%)
29.50Low
Today’s Performance
31.40High
26.10Low
52 Week’s Performance
44.96High

bt_logoStock Performance

  • 1 Day-3.34%
  • 1 Week-3.22%
  • 1 Month-6.49%
  • 3 Months-14.25%
  • 6 Months-9.93%
  • 1 Year-17.60%
  • 3 Years0.77%
  • 5 Years10.20%

bt_logoPeer Comparison

Price

bt_logoStock Summary

  • Face Value (₹)10.00
  • Beta0.62
  • 52-Week Low (₹)26.10
  • 52-Week High (₹)44.96
  • Price-to-Book (X)*0.90
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*-759.75
  • Earnings Per Share (₹)-0.04
  • Market Cap (₹ Cr.)*30.39
* Values as of last close price

bt_logoCOMPETITORS

BT TV

Trump Tariff| Kenneth Andrade on India’s Resilience Amid Trade Uncertaint1:33Trump Tariff | Kenneth Andrade on India’s Resilience Amid Trade Uncertainty
Being Polite To ChatGPT Could Be Costing Millions: The Shocking Reality Behind AI's Hidden Energy4:38Being Polite To ChatGPT Could Be Costing Millions: The Shocking Reality Behind AI's Hidden Energy
Understanding The Impact Of India’s Suspension Of The Indus Water Treaty On Pakistan5:16Understanding The Impact Of India’s Suspension Of The Indus Water Treaty On Pakistan
Jim Rogers: India’s Shift Toward Prosperity Makes Its Market a Global Investor’s Dream0:54Jim Rogers: India’s Shift Toward Prosperity Makes Its Market a Global Investor’s Dream
From Cement To Coal: Best Domestic Plays Amid Global Trade Uncertainty1:43From Cement To Coal: Best Domestic Plays Amid Global Trade Uncertainty
Pahalgam Attack: Emotional Burst Of Victims, Survivors & Kashmiri Locals2:58Pahalgam Attack: Emotional Burst Of Victims, Survivors & Kashmiri Locals
Domestic Focus, Global Reach: Jindal Stainless8:54Domestic Focus, Global Reach: Jindal Stainless
Piyush Goyal Urges Industry To Back 'Make In India', Warns Against Irregular Trade Practices3:40Piyush Goyal Urges Industry To Back 'Make In India', Warns Against Irregular Trade Practices
Nine Indian Banks Among Forty Global Digital Champions: Deloitte Report19:05Nine Indian Banks Among Forty Global Digital Champions: Deloitte Report
India-Pak Tensions Rattle Markets | Sensex Tanks 400 Pts, Nifty Sees Sharp Drop8:47India-Pak Tensions Rattle Markets | Sensex Tanks 400 Pts, Nifty Sees Sharp Drop
View more

bt_logoFinancial Analysis

Income Statement (₹ Cr.)

No data for consolidated quarterly .

Balance Sheet (₹ Cr.)

No data for consolidated quarterly .

Cash Flow (₹ Cr.)

No data for consolidated quarterly .

bt_logoRatio Analysis

Return on Equity (%)
No Data For consolidated ROE.
Return on Assets (%)
No Data For consolidated ROE.
Price-to-Earnings (P/E) (X)
No Data For consolidated ROE.
Price to Book (x)
No Data For consolidated ROE.
Return on Capital Employed (%)
No Data For consolidated ROE.
Enterprise Value to EBITDA (X)
No Data For consolidated ROE.
Net Profit Margin (%)
No Data For consolidated ROE.
Gross Profit Margin (%)
No Data For consolidated ROE.
EBITDA Margin (%)
No Data For consolidated ROE.

bt_logoShare Holding Pattern

Summary (As on 31 Mar 2025)

bt_logoDeals

No data for block deals

bt_logoFAQ's

What was Concord Drugs Ltd share price previously?
Concord Drugs Ltd share price was down by -3.34% from the previous closing price of ₹31.44.
Who are peers of Concord Drugs Ltd?
The peers of Concord Drugs Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd.
Who is/are the promoter/promoters of Concord Drugs Ltd?
The promotor/promotors of Concord Drugs Ltd are S Nagi Reddy, K Ramchandra Reddy, Koni Reddy, S. Nagavenkata Hareesh, S. Manoj Kumar Reddy, Summela Kasu, Namratha Nagla.
What has been 52-week high of Concord Drugs Ltd stocks?
The highest price of Concord Drugs Ltd stock is ₹44.96 in the last 52-week.
What is the share price of Concord Drugs Ltd (CONCORD) today on BSE?
As on Apr 25, 2025 Concord Drugs Ltd (CONCORD)’s share price on BSE is Rs 30.39
What is the market cap of Concord Drugs Ltd (CONCORD)?
The current market capitalisation of Concord Drugs Ltd (CONCORD) is 30.39 crores
What is Concord Drugs Ltd Share symbol?
The symbol of Concord Drugs Ltd is .
What is the PE ratio of Concord Drugs Ltd (CONCORD)?
The current PE ratio of Concord Drugs Ltd (CONCORD) is -759.75.
What is the PB ratio of Concord Drugs Ltd (CONCORD)?
The current PB ratio of Concord Drugs Ltd (CONCORD) is 0.90.
Today’s High & Low share prices of Concord Drugs Ltd (CONCORD) on BSE?
Today, the share price of Concord Drugs Ltd (CONCORD) on BSE touched a high of Rs 31.4 and a low of Rs 29.5
What price did Concord Drugs Ltd (CONCORD) shares open on the BSE today?
On BSE, the share price of Concord Drugs Ltd (CONCORD) opened at Rs 31.4
What is the 52-week high of Concord Drugs Ltd (CONCORD)?
The 52-week high price of Concord Drugs Ltd (CONCORD) is Rs 44.96
What is the 52-week low of Concord Drugs Ltd (CONCORD)?
The 52-week low price of Concord Drugs Ltd (CONCORD) is Rs 26.10

bt_logoAbout Concord Drugs

Concord Drugs Ltd, incorporated in the year 1995, has its registered office in Survey No 249 Brahmanapally V, Hayathnagar M, Ranga Reddy, Telangana, 501511, 91-40-24036379. The main industry in which Concord Drugs Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Concord Drugs Ltd is/are Pundarikashyam and Associates. In the main management, S Nagi Reddy is chairman and Namratha Nagla is the company secretary for Concord Drugs Ltd.

  • SNR
    S Nagi ReddyChairman & Managing Director
  • KRR
    K Ramchandra ReddyIndependent Director
  • KR
    Koni ReddyWhole Time Director & CFO
  • SNH
    S. Nagavenkata HareeshIndependent Director
  • SMKR
    S. Manoj Kumar ReddyWhole-time Director
  • SK
    Summela KasuIndependent Director
  • NN
    Namratha NaglaCompany Sec. & Compli. Officer

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.